170 related articles for article (PubMed ID: 18433468)
1. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk.
Suchy J; Kłujszo-Grabowska E; Kładny J; Cybulski C; Wokołorczyk D; Szymańska-Pasternak J; Kurzawski G; Scott RJ; Lubiński J
BMC Cancer; 2008 Apr; 8():112. PubMed ID: 18433468
[TBL] [Abstract][Full Text] [Related]
2. Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases.
Cucchiara S; Latiano A; Palmieri O; Staiano AM; D'Incà R; Guariso G; Vieni G; Rutigliano V; Borrelli O; Valvano MR; Annese V
World J Gastroenterol; 2007 Feb; 13(8):1221-9. PubMed ID: 17451203
[TBL] [Abstract][Full Text] [Related]
3. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Cucchiara S; Riegler G; Staiano AM; Ardizzone S; Accomando S; de Angelis GL; Corritore G; Bossa F; Annese V
World J Gastroenterol; 2008 Aug; 14(29):4643-51. PubMed ID: 18698678
[TBL] [Abstract][Full Text] [Related]
4. Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study.
Ferraris A; Torres B; Knafelz D; Barabino A; Lionetti P; de Angelis GL; Iacono G; Papadatou B; D'Amato G; Di Ciommo V; Dallapiccola B; Castro M
Inflamm Bowel Dis; 2006 May; 12(5):355-61. PubMed ID: 16670523
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort.
Tremelling M; Waller S; Bredin F; Greenfield S; Parkes M
Inflamm Bowel Dis; 2006 Mar; 12(3):178-84. PubMed ID: 16534418
[TBL] [Abstract][Full Text] [Related]
6. OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease.
Li M; Gao X; Guo CC; Wu KC; Zhang X; Hu PJ
World J Gastroenterol; 2008 Aug; 14(31):4923-7. PubMed ID: 18756601
[TBL] [Abstract][Full Text] [Related]
7. The role of genetics in inflammatory bowel disease.
Henckaerts L; Figueroa C; Vermeire S; Sans M
Curr Drug Targets; 2008 May; 9(5):361-8. PubMed ID: 18473763
[TBL] [Abstract][Full Text] [Related]
8. NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.
Lin Z; Hegarty JP; John G; Berg A; Wang Z; Sehgal R; Pastor DM; Wang Y; Harris LR; Poritz LS; Schreiber S; Koltun WA
Dig Dis Sci; 2013 Sep; 58(9):2599-607. PubMed ID: 23709157
[TBL] [Abstract][Full Text] [Related]
9. Pediatric inflammatory bowel disease: clinical and molecular genetics.
Biank V; Broeckel U; Kugathasan S
Inflamm Bowel Dis; 2007 Nov; 13(11):1430-8. PubMed ID: 17600381
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.
Török HP; Glas J; Tonenchi L; Lohse P; Müller-Myhsok B; Limbersky O; Neugebauer C; Schnitzler F; Seiderer J; Tillack C; Brand S; Brünnler G; Jagiello P; Epplen JT; Griga T; Klein W; Schiemann U; Folwaczny M; Ochsenkühn T; Folwaczny C
Gut; 2005 Oct; 54(10):1421-7. PubMed ID: 15955786
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis.
Tian Y; Li Y; Hu Z; Wang D; Sun X; Ren C
Int J Colorectal Dis; 2010 Feb; 25(2):161-8. PubMed ID: 19787357
[TBL] [Abstract][Full Text] [Related]
12. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?
Lakatos PL; Fischer S; Lakatos L; Gal I; Papp J
World J Gastroenterol; 2006 Mar; 12(12):1829-41. PubMed ID: 16609988
[TBL] [Abstract][Full Text] [Related]
13. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients.
Lakatos PL; Hitre E; Szalay F; Zinober K; Fuszek P; Lakatos L; Fischer S; Osztovits J; Gemela O; Veres G; Papp J; Ferenci P
BMC Cancer; 2007 Mar; 7():54. PubMed ID: 17389035
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease.
Gazouli M; Mantzaris G; Archimandritis AJ; Nasioulas G; Anagnou NP
World J Gastroenterol; 2005 Dec; 11(47):7525-30. PubMed ID: 16437728
[TBL] [Abstract][Full Text] [Related]
15. Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.
Möckelmann N; von Schönfels W; Buch S; von Kampen O; Sipos B; Egberts JH; Rosenstiel P; Franke A; Brosch M; Hinz S; Röder C; Kalthoff H; Fölsch UR; Krawczak M; Schreiber S; Bröring CD; Tepel J; Schafmayer C; Hampe J
BMC Gastroenterol; 2009 Oct; 9():79. PubMed ID: 19843337
[TBL] [Abstract][Full Text] [Related]
16. 3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer.
Omrane I; Mezlini A; Baroudi O; Stambouli N; Bougatef K; Ayari H; Medimegh I; Bouzaienne H; Uhrhammer N; Bignon YJ; Benammar-Elgaaied A; Marrakchi R
Med Oncol; 2014 May; 31(5):954. PubMed ID: 24719038
[TBL] [Abstract][Full Text] [Related]
17. Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population.
Pearce AV; Fisher SA; Prescott NJ; Onnie CM; Pattni R; Green P; Forbes A; Mansfield J; Sanderson J; Schreiber S; Lewis CM; Mathew CG
Int J Colorectal Dis; 2007 Apr; 22(4):419-24. PubMed ID: 16944184
[TBL] [Abstract][Full Text] [Related]
18. Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population.
Papaconstantinou I; Theodoropoulos G; Gazouli M; Panoussopoulos D; Mantzaris GJ; Felekouras E; Bramis J
Int J Cancer; 2005 Apr; 114(3):433-5. PubMed ID: 15578724
[TBL] [Abstract][Full Text] [Related]
19. DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.
Noble CL; Nimmo ER; Drummond H; Smith L; Arnott ID; Satsangi J
Gut; 2005 Oct; 54(10):1416-20. PubMed ID: 15843420
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease.
de Ridder L; Weersma RK; Dijkstra G; van der Steege G; Benninga MA; Nolte IM; Taminiau JA; Hommes DW; Stokkers PC
Inflamm Bowel Dis; 2007 Sep; 13(9):1083-92. PubMed ID: 17476680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
